Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BATS BZX Real-Time Price
As of 1:40pm ET
 -1.75 / -2.84%
Today’s Change
Today|||52-Week Range
Trump warns Wall Street: I'm going to cut drug prices
10:40am / CNNMoney.com
Momenta Pharmaceuticals Announces Positive Results for Humira Biosimilar
Nov 30 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus
9:32am / Zacks.com - Paid Partner Content
Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov 30 / Zacks.com - Paid Partner Content
AbbVie, Johns Hopkins Unite for Cancer Research
Dec 06 / GuruFocus News - Paid Partner Content
Why the $324 Billion Bioeconomy Deserves a Place in Your Portfolio
Nov 30 / MotleyFool.com - Paid Partner Content
AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH
Dec 06 / Zacks.com - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content
Leukemia Treatment Achieves Promising Results
Dec 05 / GuruFocus News - Paid Partner Content
3 Top Drug Stocks for Your Retirement Portfolio
Nov 28 / MotleyFool.com - Paid Partner Content
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Dec 05 / Zacks.com - Paid Partner Content
J&J confirms talks with Actelion over pharma deal
Nov 25 / FT.com - Paid Partner Content
FDA Orphan Drug Designation for AbbVie's Risankizumab
Dec 01 / GuruFocus News - Paid Partner Content
Galapagos (GLPG) Filgotinib in Phase III for Crohn's Disease
Nov 23 / Zacks.com - Paid Partner Content
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Dec 01 / Zacks.com - Paid Partner Content
US stocks defy fears of panic with steady open after Trump win
Nov 09 / FT.com - Paid Partner Content